Pep Coll

3.7k total citations
19 papers, 138 citations indexed

About

Pep Coll is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Pep Coll has authored 19 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 7 papers in Virology. Recurrent topics in Pep Coll's work include HIV/AIDS Research and Interventions (12 papers), HIV, Drug Use, Sexual Risk (9 papers) and HIV Research and Treatment (7 papers). Pep Coll is often cited by papers focused on HIV/AIDS Research and Interventions (12 papers), HIV, Drug Use, Sexual Risk (9 papers) and HIV Research and Treatment (7 papers). Pep Coll collaborates with scholars based in Spain, Israel and United Kingdom. Pep Coll's co-authors include James T Pacala, Michael Meulbroek, Carlos Iniesta, Bonaventura Clotet, Asunción Díaz, José Moltó, Verónica Saludes, Beatriz Mothe, María Jesús Barberà and Miguel García Deltoro and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Pep Coll

15 papers receiving 134 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pep Coll Spain 7 82 78 39 32 25 19 138
Jeremy Chow United States 6 72 0.9× 81 1.0× 34 0.9× 46 1.4× 16 0.6× 26 156
Anna Favia Italy 4 65 0.8× 106 1.4× 65 1.7× 15 0.5× 27 1.1× 7 147
Danièle Longpré Canada 6 135 1.6× 175 2.2× 53 1.4× 70 2.2× 22 0.9× 13 221
Miguel Rocha Portugal 7 76 0.9× 73 0.9× 10 0.3× 48 1.5× 48 1.9× 18 135
Benjamin Hampel Switzerland 7 76 0.9× 79 1.0× 26 0.7× 12 0.4× 33 1.3× 10 132
Margaret Camarca United States 10 87 1.1× 114 1.5× 60 1.5× 4 0.1× 41 1.6× 11 203
Richard E. Haaland United States 10 100 1.2× 177 2.3× 77 2.0× 25 0.8× 53 2.1× 23 249
Sherri Johnson United States 6 65 0.8× 152 1.9× 96 2.5× 11 0.3× 54 2.2× 13 199
Gabriel Schembri United Kingdom 8 46 0.6× 61 0.8× 24 0.6× 6 0.2× 49 2.0× 19 142
Killian Quinn United Kingdom 6 75 0.9× 81 1.0× 32 0.8× 25 0.8× 8 0.3× 7 110

Countries citing papers authored by Pep Coll

Since Specialization
Citations

This map shows the geographic impact of Pep Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pep Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pep Coll more than expected).

Fields of papers citing papers by Pep Coll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pep Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pep Coll. The network helps show where Pep Coll may publish in the future.

Co-authorship network of co-authors of Pep Coll

This figure shows the co-authorship network connecting the top 25 collaborators of Pep Coll. A scholar is included among the top collaborators of Pep Coll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pep Coll. Pep Coll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bailón, Lucía, Àngel Rivero, Pep Coll, et al.. (2025). Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program. Open Forum Infectious Diseases. 12(9). ofaf545–ofaf545.
2.
Seguí, Francesc López, Pep Coll, Michael Meulbroek, et al.. (2023). Cost-effectiveness analysis of the daily HIV pre-exposure prophylaxis in men who have sex with men in Barcelona. PLoS ONE. 18(1). e0277571–e0277571. 3 indexed citations
3.
Coll, Pep, et al.. (2023). Achieving the UNAIDS goals by 2030 in people living with HIV: A simulation model to support the prioritization of health care interventions. Enfermedades infecciosas y microbiologia clinica (English ed ). 41(10). 589–595. 1 indexed citations
4.
Pérez‐González, Alexandre, et al.. (2022). Real-life cohort experience after implementing HIV pre-exposure prophylaxis for one year in northwest Spain. Frontiers in Public Health. 10. 1005622–1005622.
5.
Coll, Pep, et al.. (2022). Achieving the UNAIDS goals by 2030 in people living with HIV: A simulation model to support the prioritization of health care interventions. Enfermedades Infecciosas y Microbiología Clínica. 41(10). 589–595. 4 indexed citations
6.
Llano, Anuska, Santiago Cedeño, Pep Coll, et al.. (2021). A placebo-controlled ati trial of HTI vaccines in early treated HIV infection. 29(1). 48–49. 5 indexed citations
7.
Iniesta, Carlos, Pep Coll, María Jesús Barberà, et al.. (2021). Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models. PLoS ONE. 16(2). e0246129–e0246129. 16 indexed citations
8.
Prats, Anna, Ignacio Martínez‐Zalacaín, Beatriz Mothe, et al.. (2021). Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection. Scientific Reports. 11(1). 9 indexed citations
9.
Rosás-Umbert, Míriam, Marta Ruiz‐Riol, Marco A. Fernández, et al.. (2020). In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial. Frontiers in Immunology. 11. 418–418. 20 indexed citations
10.
Mir, Joan Francesc, et al.. (2020). Implementation models and access to HIV pre-exposure prophylaxis in Spain. Enfermedades infecciosas y microbiologia clinica (English ed ). 38(5). 234–237. 1 indexed citations
11.
Mir, Joan Francesc, et al.. (2019). Modelos de implementación y acceso a la profilaxis preexposición para el VIH en España. Enfermedades Infecciosas y Microbiología Clínica. 38(5). 234–237. 1 indexed citations
12.
Iniesta, Carlos, Débora Álvarez-del Arco, Belén Alejos, et al.. (2018). Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017. PLoS ONE. 13(10). e0204738–e0204738. 22 indexed citations
13.
14.
Fernández, Gema, Elisa Martró, Victoria González, et al.. (2015). Usefulness of a novel multiplex real-time PCR assay for the diagnosis of sexually-transmitted infections. Enfermedades Infecciosas y Microbiología Clínica. 34(8). 471–476. 26 indexed citations
15.
Morón‐López, Sara, Beatriz Mothe, Christian Manzardo, et al.. (2015). HIV conserved region vaccine in early cART-treated subjects (BCN01): impact on immunogenicity and the latent reservoir. Journal of Virus Eradication. 1. 14–15. 1 indexed citations
16.
Coll, Pep. (2014). El segle de la llum. Dialnet (Universidad de la Rioja).
17.
Coll, Pep, et al.. (2000). Successful Withdrawal of Thyroid Hormone Therapy in Nursing Home Patients. The Journal of the American Board of Family Medicine. 13(6). 403–407. 6 indexed citations
18.
Coll, Pep, et al.. (1992). Cytomegalovirus colitis in an older woman, successfully treated with ganciclovir.. PubMed. 34(6). 772–5. 13 indexed citations
19.
Coll, Pep. (1991). El parlar del pallars. 197–200.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeremy Chow Breakdown of academic impact, for papers by Anna Favia Breakdown of academic impact, for papers by Danièle Longpré Breakdown of academic impact, for papers by Miguel Rocha Breakdown of academic impact, for papers by Benjamin Hampel Breakdown of academic impact, for papers by Margaret Camarca Breakdown of academic impact, for papers by Richard E. Haaland Breakdown of academic impact, for papers by Sherri Johnson Breakdown of academic impact, for papers by Gabriel Schembri Breakdown of academic impact, for papers by Killian Quinn
Rankless by CCL
2026